|Articles|August 2, 2017

Biosurveillance Integration: Coverage From the Biodefense World Summit

Biosurveillance plays a vital role in biodefense efforts.

Perhaps one of the most captivating topics addressed at the 2017 Biodefense World Summit was biosurveillance integration. Here I present an overview of some of my favorite talks during this engaging and insightful breakout session.

Alina Deshpande, PhD, from Los Alamos National Laboratory spoke about “Tools and Apps to Enhance Situational Awareness for Global Disease Surveillance.” This was particularly interesting as right away I was curious what exactly “situational awareness” meant in this situation. Drawing on a classic definition that included the perception of the elements in one’s environment within a given time and space, Dr. Deshpande’s talk centered around the analytics used for investigating a disease outbreak, specifically how one might contextualize the outbreak.

She remarked on how there are two functionalities at play during an outbreak: understanding the unfolding outbreak and learning about representative global historical outbreaks. These two components aid in short-term forecasting and help provide structure as an outbreak begins to unfold.

Dr. Deshpande also highlighted several decision-support tools for biosurveillance, such as Analytics for Investigation of Disease Outbreaks (AIDO), Red Alert, Biosurveillance Resource Directory (BRD), and Epi Archive. By using these tools and addressing certain components—such as herd immunity, nosocomial transmission, etc—one can help predict and respond to outbreaks in a more efficient and effective manner.

Luther Lindler, PhD, from Bio Programs within the Department of Homeland Security (DHS) presented perhaps one of my favorite talks regarding biosurveillance and its application as a measure of homeland security. Dr. Lindler highlighted the role of biosurveillance within the scope of DHS by pointing to the threat space, which ranges from deliberate use of biological weapons (by states or terrorists), accidents or negligence, to natural outbreaks. Within the biodefense realm, the DHS plays an integral role and utilizes a four-pronged approach—threat awareness, prevent and protect, surveillance and detection, and response and recover.

Perhaps one of the most eye-opening points Dr. Lindler made was when remarking on a day in the life of those officers who work in Customs and Border Patrol (CBP). A typical day includes reviewing and processing over 1 million passengers and pedestrians, $6.3 billion worth of imported products, 404 pests discovered at US ports of entry, and 4638 materials held for quarantine.

These operations are conducted in 51 countries, and are just a glimpse into the overwhelming efforts that are needed to monitor and protect health security within the United States. Biosensors and biodetection efforts are also a large part of these efforts and an ongoing application for biodefense efforts within buildings for large events such as the Super Bowl, and other high risk environments. DHS biosurveillance efforts encompass a magnitude of scenarios and environments, which Dr. Lindler highlighted through his examples of CBP as just one facet of American biodefense efforts.

Dr. Lindler also highlighted the airport screening processes that were used during the Ebola outbreak and how non-invasive screening is often done during such global public health events. Overall, there is a multitude of biosurveillance components that DHS relies on for biodefense efforts, whether it be at ports, airports, or government buildings. DHS must ensure biosurveillance efforts are just as diverse as the variety of biological threats the United States faces.

Finally, one of the most meaningful (and relevant) talks of this section of the summit was led by Chris R. Taitt, PhD, from the US Naval Research Laboratory, who discussed biosurveillance in resource limited environments. Traditionally, we tend to think about biosurveillance in terms of the United States or other industrialized countries, which have a wealth of resources and personnel; however, in the art of global health security and biodefense, we are only as strong as the weakest country. Ensuring biosurveillance at all levels is vital for this goal.

Because infectious diseases are a global problem, and as Dr. Taitt highlighted, a military problem, there is a need for real-time biosurveillance. To this end, Dr. Taitt pointed to the Defense Threat Reduction Agency’s (DTRA), 24-Month Challenge to get real-time biosurveillance up and running in a resource-limited country. Sierra Leone was chosen as the test site. To truly understand the challenges, we have to consider everything, from power availability, road conditions, to the weather, and more.

The 24-Month Challenge included 2863 enrolled subjects and a series of tests from diseases such as malaria, Dengue, and other tropical diseases (tested via peripheral whole blood). In addition to the biosurveillance the researchers captured, there were also some unexpected findings, such as the modifications that are needed in developing nations with regards to literacy, sample collection, and familiarity with standard supplies. Aside from modifying these practices and training personnel, there existed a significant potential for co-infections and the simple truth that basic devices and tests that are expected to work, just won’t in a resource-limited country.

Dr. Taitt drew our attention to the fact that, overall, resource-limited countries present new and unique challenges in terms in biosurveillance; however, addressing and acknowledging these challenges will be vital for overall global health security efforts.


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.